Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma
Status:
Terminated
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research is to learn if the combination of Genasense (oblimersen),
carboplatin, and paclitaxel (GCP) can help to control metastatic uveal melanoma. The safety
of this combination will also be studied.